CORRECTION FROM SOURCE: The Nomination Committee’s Proposal for New Board Members
This corrects and replaces a release that posted earlier today. GOTHENBURG, SE / ACCESS Newswire / February 20, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) – Correction: In the press release that was distributed today at 2:00 p.m. CET, the…
Continue Reading